JP2021535147A5 - - Google Patents
Info
- Publication number
- JP2021535147A5 JP2021535147A5 JP2021510761A JP2021510761A JP2021535147A5 JP 2021535147 A5 JP2021535147 A5 JP 2021535147A5 JP 2021510761 A JP2021510761 A JP 2021510761A JP 2021510761 A JP2021510761 A JP 2021510761A JP 2021535147 A5 JP2021535147 A5 JP 2021535147A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutically acceptable
- composition
- acceptable salt
- teeth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862725941P | 2018-08-31 | 2018-08-31 | |
| US62/725,941 | 2018-08-31 | ||
| PCT/US2019/049195 WO2020047496A1 (en) | 2018-08-31 | 2019-08-30 | Isoquinoline-steroid conjugates and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021535147A JP2021535147A (ja) | 2021-12-16 |
| JP2021535147A5 true JP2021535147A5 (enExample) | 2022-08-31 |
| JP7437384B2 JP7437384B2 (ja) | 2024-02-22 |
Family
ID=69639319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021510761A Active JP7437384B2 (ja) | 2018-08-31 | 2019-08-30 | イソキノリンステロイド抱合体およびその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11059789B2 (enExample) |
| EP (1) | EP3843736A4 (enExample) |
| JP (1) | JP7437384B2 (enExample) |
| KR (1) | KR20210053301A (enExample) |
| CN (1) | CN112638386A (enExample) |
| AU (2) | AU2019328590B2 (enExample) |
| BR (1) | BR112021003613A2 (enExample) |
| MX (1) | MX2021002380A (enExample) |
| SG (1) | SG11202101517PA (enExample) |
| WO (1) | WO2020047496A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020047496A1 (en) | 2018-08-31 | 2020-03-05 | Aerie Pharmaceuticals, Inc. | Isoquinoline-steroid conjugates and uses thereof |
| US12509469B2 (en) | 2019-08-07 | 2025-12-30 | Ripple Therapeutics Corporation | Compositions and methods for the treatment of pain and dependence disorders |
| WO2021207486A1 (en) * | 2020-04-08 | 2021-10-14 | Aerie Pharmaceuticals, Inc. | Treatments |
| CA3176134A1 (en) * | 2020-05-01 | 2021-11-04 | Ripple Therapeutics Corporation | Heterodimer compositions and methods for the treatment of ocular disorders |
| AU2022264917A1 (en) * | 2021-04-29 | 2023-11-02 | Alcon Inc. | Stable isoquinoline-corticosteroid conjugates and uses thereof |
| EP4426712A4 (en) * | 2021-11-03 | 2026-04-08 | Ripple Therapeutics Corp | COMPOSITIONS SUITABLE FOR PROCESSING AND THEIR USE |
| CN115340472B (zh) * | 2022-09-19 | 2024-05-07 | 合肥工业大学 | 一种谷氨酸衍生物及其合成方法和应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3193459A (en) * | 1955-07-01 | 1965-07-06 | Upjohn Co | Steroid hemisuccinate compositions and method for extemporaneous administration |
| ES2580108T3 (es) * | 2005-07-11 | 2016-08-19 | Aerie Pharmaceuticals, Inc | Compuestos de isoquinolina |
| US8455513B2 (en) * | 2007-01-10 | 2013-06-04 | Aerie Pharmaceuticals, Inc. | 6-aminoisoquinoline compounds |
| MX2009008334A (es) * | 2007-02-05 | 2009-08-12 | Nicox Sa | Esteroides que liberan oxido nitrico. |
| US8450344B2 (en) * | 2008-07-25 | 2013-05-28 | Aerie Pharmaceuticals, Inc. | Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
| WO2010126626A2 (en) * | 2009-05-01 | 2010-11-04 | Aerie Pharmaceuticals, Inc. | Dual mechanism inhibitors for the treatment of disease |
| WO2014138359A1 (en) * | 2013-03-08 | 2014-09-12 | Allergan, Inc. | Steroid antibiotic conjugates |
| BR112015021836A2 (pt) * | 2013-03-08 | 2017-07-18 | Allergan Inc | conjugados de antibióticos diretamente ligados com drogas esteroides |
| ES2776199T3 (es) * | 2013-03-15 | 2020-07-29 | Aerie Pharmaceuticals Inc | Conjugados de compuestos de isoquinolina y prostaglandinas |
| JP2019529359A (ja) * | 2016-08-19 | 2019-10-17 | アエリエ ファーマシューティカルズ インコーポレイテッド | ベータ−アミノ−イソキノリニルアミド化合物 |
| WO2020047496A1 (en) | 2018-08-31 | 2020-03-05 | Aerie Pharmaceuticals, Inc. | Isoquinoline-steroid conjugates and uses thereof |
-
2019
- 2019-08-30 WO PCT/US2019/049195 patent/WO2020047496A1/en not_active Ceased
- 2019-08-30 MX MX2021002380A patent/MX2021002380A/es unknown
- 2019-08-30 US US16/557,779 patent/US11059789B2/en active Active
- 2019-08-30 JP JP2021510761A patent/JP7437384B2/ja active Active
- 2019-08-30 AU AU2019328590A patent/AU2019328590B2/en not_active Ceased
- 2019-08-30 SG SG11202101517PA patent/SG11202101517PA/en unknown
- 2019-08-30 BR BR112021003613-0A patent/BR112021003613A2/pt not_active Application Discontinuation
- 2019-08-30 EP EP19853977.7A patent/EP3843736A4/en not_active Withdrawn
- 2019-08-30 CN CN201980056414.7A patent/CN112638386A/zh active Pending
- 2019-08-30 KR KR1020217008114A patent/KR20210053301A/ko not_active Abandoned
-
2021
- 2021-06-04 US US17/339,828 patent/US11691950B2/en active Active
-
2023
- 2023-07-12 AU AU2023204624A patent/AU2023204624A1/en not_active Abandoned